AHA Scientific Sessions 2022
The AHA scientific sessions 2022 will be held from November 5—7, 2022, where more than 15,000 delegates will meet virtually and in-person in Chicago, IL. Clinicians, scientists and AHA members, including Massachusetts General Hospital experts, will gather together and be part of this year's scientific and global education sessions.
It's been 100 years since the American Heart Association (AHA) began supporting and focusing on the advancement of cardiovascular science. The AHA was founded in the year 1924 by six cardiologists, and today it has more than a thousand members who have dedicated their knowledge to better heart health. This year's event marks the 75th anniversary of AHA and takes place both virtually and in-person at the McCormick Place Convention Center in Chicago, IL.
These sessions are aimed at improving cardiovascular health and science. Some of the topics covered throughout the event include:
- Championing scientific discovery and clinical practice
- Heart failure guidelines
- Profiles in cardiovascular diseases
- Imaging of structural heart interventions
Presenters and Topics
David M. Dudzinski, MD
How Do We Make More? The Training Pathway for Critical Care Cardiologists
Poster Professor: Clinical Cases in Critical Care Cardiology
Poster Professor: Multidisciplinary Care in Critical Care Cardiology
Hanna K. Gaggin, MD, MPH
Poster: Contemporary Outpatient Management of Patients With and Without Worsening Heart Failure With Reduced Ejection Fraction Within a Single Integrated System: Results From Electronic Medical Record Data in the Chart-HF Study
Thomas Gilliland
Abstract: Lipoprotein(a), Oxidized Phospholipids, and Coronary Disease Severity and Outcomes
Simran Grewal, DO
Genetic and Neurobiological Factors Link Chronic Stress to Earlier Onset Hypertension
Nkechinyere N. Ijioma, MBBS
Case of a Patient With Diabetes and Angina
Shaan Khurshid, MD
Poster: Electrocardiogram-based Deep Learning to Predict Peak Oxygen Consumption During Exercise
Ik-Kyung Jang, MD, PhD
Debate 2: Pro: Plaque Erosion Should Be Treated With Anti-thrombotic, Not a Stent
Adam L. Johnson, MD
Janet Ma, MD
Obesity Modifies Clinical Outcomes of RV Dysfunction
Cian P. McCarthy, MD
Implementation of High Sensitivity Cardiac Troponin Assays in the United States: A Report From the NCDR Chest Pain—MI Registry
Pradeep Natarajan, MD, MMSc
Power to the People: Direct to Consumer Genetic Testing
Inherited Causes of Clonal Hematopoiesis in Whole Genomes—Link to Cardiovascular Disease
Ohad Oren, MD
Cardiotoxicity Based Model for Assessment of Drug Value in Breast Cancer
Antonia van Kampen, MD
Mitral Valve Prolapse Increases the Force Exerted on the Papillary Muscles
Rory B. Weiner, MD
Poster: Frequency and Impact of Repeat Transthoracic Echocardiography in Inpatients Transferred for Transcatheter Aortic Valve Replacement
Poster: Characterization of Heart Failure Patients in an Academic Home Hospital Program and Identification of Patient Factors Requiring Escalation of Care
Malissa J. Wood, MD
Managing Acute Coronary Syndromes in Women: Why and When Is a Unique Approach Required